The leading cause of tonsil cancer is infection with human papillomavirus, specifically HPV-16. Over 70% of oropharyngeal squamous cell cancers (the category that includes tonsil cancer) are now linked to HPV, a dramatic increase from roughly 20% in the 1980s. Tobacco and alcohol use account for most remaining cases, and the combination of the two raises risk far more than either one alone.
HPV-16 and How It Drives Tonsil Cancer
More than 90% of HPV-positive tonsil cancers are caused by a single strain: HPV-16. The virus doesn’t cause cancer overnight. After infecting cells in the tonsil lining, HPV produces proteins that disable two of the body’s key tumor-suppressing systems. One protein, E6, breaks down the p53 protein that normally triggers damaged cells to self-destruct. Another, E7, disables the retinoblastoma protein (Rb) that keeps cell division in check. With both brakes removed, infected cells can accumulate genetic damage and eventually become cancerous, often years or decades after the initial infection.
HPV can also weaken the immune system’s ability to detect and clear the virus. In some cases, molecular defects in certain immune-signaling genes reduce the cell’s production of antiviral proteins, allowing the virus to persist without triggering an immune response. This silent persistence is a key reason tonsil cancer can develop so long after exposure.
Why the Tonsils Are Especially Vulnerable
Your tonsils aren’t smooth tissue. They’re covered in deep folds called crypts, and their structure makes them uniquely hospitable to HPV. The lining of these crypts has a discontinuous basement membrane and is rich in small blood vessels, both features that make it easier for the virus to reach and infect the deeper basal cells where it can establish a long-term foothold.
Bacterial biofilm, a sticky community of microbes, also collects inside these crypts. Research published in JAMA Otolaryngology found that HPV colocalizes with this biofilm, meaning the virus can essentially hide within it. This creates a reservoir of virus particles shielded from immune detection. When these dormant particles reactivate and infect nearby cells, they can set off the chain of events that leads to cancer. It’s no coincidence that HPV-associated tonsil cancers are reported to arise largely from the crypt tissue itself.
Tobacco and Alcohol as Risk Factors
Before the rise of HPV-related cases, tobacco and alcohol were the primary causes of tonsil and other throat cancers, and they remain significant risk factors today. Smoking exposes the throat lining to dozens of carcinogens that damage DNA directly. Alcohol acts as a solvent, increasing the permeability of the tissue lining so that these carcinogens penetrate more easily. It also breaks down in the body into acetaldehyde, which is itself a known carcinogen.
The real danger comes from using both together. The combined effect on oral and pharyngeal cancer risk is multiplicative: you don’t simply add the two risks, you multiply them. Some studies have found even greater-than-multiplicative effects. One study found that heavy drinkers who also smoked had a 300-fold higher risk of oral and pharyngeal cancers compared to people who did neither. This makes the tobacco-alcohol combination one of the strongest known synergistic cancer risks in the body.
Who Gets Tonsil Cancer
The median age at diagnosis for HPV-associated oropharyngeal cancers is 63 for men and 64 for women. However, the demographic profile has shifted considerably over the past few decades. HPV-driven tonsil cancer disproportionately affects men, and the typical patient is now less likely to be a longtime smoker and more likely to be someone with a history of HPV exposure. This shift has caught many people off guard because tonsil cancer was traditionally associated with older adults who used tobacco heavily.
One important distinction: HPV-positive tonsil cancer responds significantly better to treatment than HPV-negative tonsil cancer. A study tracking patients over five years found disease-specific survival of about 86% for HPV-positive cases compared to just 11% for HPV-negative cases. This gap is one of the largest survival differences seen in any cancer subtype and is a major factor in how doctors plan treatment.
Early Signs to Recognize
Tonsil cancer often starts with symptoms that feel minor and easy to dismiss. The most common early signs include difficulty swallowing, a persistent feeling that something is stuck in the back of the throat, earache (often on one side), swelling or pain in the neck, and jaw stiffness. Many of these overlap with common infections, which is why tonsil cancer is sometimes caught later than it should be. A sore throat or ear pain that lingers for weeks without a clear cause, especially when it’s only on one side, is worth getting checked.
Diagnosis typically starts with a physical exam of the mouth and throat, sometimes using a small camera, along with feeling the neck for swollen lymph nodes. If anything looks suspicious, a biopsy is taken, either by cutting a small sample from the tonsil or drawing cells from a swollen lymph node with a needle. Imaging with CT, MRI, or PET scans helps determine whether cancer has spread.
HPV Vaccination and Prevention
Because HPV-16 is behind the vast majority of HPV-positive tonsil cancers, vaccination offers a powerful form of prevention. A meta-analysis found that vaccinated individuals had an 80% lower chance of carrying oral HPV-16 compared to unvaccinated people. One cross-sectional study of men found zero oral HPV infections among vaccinated participants versus a 2.13% prevalence in unvaccinated men. Unvaccinated men in another study had a nearly 24-fold higher relative risk of developing oropharyngeal cancer.
The vaccine is most effective when given before any HPV exposure, which is why it’s recommended in adolescence. But even for those past the ideal window, the data consistently shows meaningful reductions in oral HPV infection after vaccination. For tobacco- and alcohol-related risk, the most direct prevention is reducing or eliminating both habits, particularly in combination.